440 related articles for article (PubMed ID: 33968608)
21. Face masks against COVID-19: Standards, efficacy, testing and decontamination methods.
Ju JTJ; Boisvert LN; Zuo YY
Adv Colloid Interface Sci; 2021 Jun; 292():102435. PubMed ID: 33971389
[TBL] [Abstract][Full Text] [Related]
22. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy.
Vitale J; Mumoli N; Clerici P; De Paschale M; Evangelista I; Cei M; Mazzone A
JAMA Intern Med; 2021 Oct; 181(10):1407-1408. PubMed ID: 34048531
[TBL] [Abstract][Full Text] [Related]
23. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Sahin U; Muik A; Vogler I; Derhovanessian E; Kranz LM; Vormehr M; Quandt J; Bidmon N; Ulges A; Baum A; Pascal KE; Maurus D; Brachtendorf S; Lörks V; Sikorski J; Koch P; Hilker R; Becker D; Eller AK; Grützner J; Tonigold M; Boesler C; Rosenbaum C; Heesen L; Kühnle MC; Poran A; Dong JZ; Luxemburger U; Kemmer-Brück A; Langer D; Bexon M; Bolte S; Palanche T; Schultz A; Baumann S; Mahiny AJ; Boros G; Reinholz J; Szabó GT; Karikó K; Shi PY; Fontes-Garfias C; Perez JL; Cutler M; Cooper D; Kyratsous CA; Dormitzer PR; Jansen KU; Türeci Ö
Nature; 2021 Jul; 595(7868):572-577. PubMed ID: 34044428
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
[TBL] [Abstract][Full Text] [Related]
25. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Frenck RW; Klein NP; Kitchin N; Gurtman A; Absalon J; Lockhart S; Perez JL; Walter EB; Senders S; Bailey R; Swanson KA; Ma H; Xu X; Koury K; Kalina WV; Cooper D; Jennings T; Brandon DM; Thomas SJ; Türeci Ö; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2021 Jul; 385(3):239-250. PubMed ID: 34043894
[TBL] [Abstract][Full Text] [Related]
26. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.
Povysil G; Butler-Laporte G; Shang N; Wang C; Khan A; Alaamery M; Nakanishi T; Zhou S; Forgetta V; Eveleigh RJ; Bourgey M; Aziz N; Jones SJ; Knoppers B; Scherer SW; Strug LJ; Lepage P; Ragoussis J; Bourque G; Alghamdi J; Aljawini N; Albes N; Al-Afghani HM; Alghamdi B; Almutairi MS; Mahmoud ES; Abu-Safieh L; El Bardisy H; Harthi FSA; Alshareef A; Suliman BA; Alqahtani SA; Almalik A; Alrashed MM; Massadeh S; Mooser V; Lathrop M; Fawzy M; Arabi YM; Mbarek H; Saad C; Al-Muftah W; Jung J; Mangul S; Badji R; Thani AA; Ismail SI; Gharavi AG; Abedalthagafi MS; Richards JB; Goldstein DB; Kiryluk K
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34043590
[TBL] [Abstract][Full Text] [Related]
27. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Au L; Fendler A; Shepherd STC; Rzeniewicz K; Cerrone M; Byrne F; Carlyle E; Edmonds K; Del Rosario L; Shon J; Haynes WA; Ward B; Shum B; Gordon W; Gerard CL; Xie W; Joharatnam-Hogan N; Young K; Pickering L; Furness AJS; Larkin J; Harvey R; Kassiotis G; Gandhi S; ; Swanton C; Fribbens C; Wilkinson KA; Wilkinson RJ; Lau DK; Banerjee S; Starling N; Chau I; ; Turajlic S
Nat Med; 2021 Aug; 27(8):1362-1366. PubMed ID: 34040262
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.
Montefusco L; Ben Nasr M; D'Addio F; Loretelli C; Rossi A; Pastore I; Daniele G; Abdelsalam A; Maestroni A; Dell'Acqua M; Ippolito E; Assi E; Usuelli V; Seelam AJ; Fiorina RM; Chebat E; Morpurgo P; Lunati ME; Bolla AM; Finzi G; Abdi R; Bonventre JV; Rusconi S; Riva A; Corradi D; Santus P; Nebuloni M; Folli F; Zuccotti GV; Galli M; Fiorina P
Nat Metab; 2021 Jun; 3(6):774-785. PubMed ID: 34035524
[TBL] [Abstract][Full Text] [Related]
29. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
Becker M; Dulovic A; Junker D; Ruetalo N; Kaiser PD; Pinilla YT; Heinzel C; Haering J; Traenkle B; Wagner TR; Layer M; Mehrlaender M; Mirakaj V; Held J; Planatscher H; Schenke-Layland K; Krause G; Strengert M; Bakchoul T; Althaus K; Fendel R; Kreidenweiss A; Koeppen M; Rothbauer U; Schindler M; Schneiderhan-Marra N
Nat Commun; 2021 May; 12(1):3109. PubMed ID: 34035301
[TBL] [Abstract][Full Text] [Related]
30. Estimating infectiousness throughout SARS-CoV-2 infection course.
Jones TC; Biele G; Mühlemann B; Veith T; Schneider J; Beheim-Schwarzbach J; Bleicker T; Tesch J; Schmidt ML; Sander LE; Kurth F; Menzel P; Schwarzer R; Zuchowski M; Hofmann J; Krumbholz A; Stein A; Edelmann A; Corman VM; Drosten C
Science; 2021 Jul; 373(6551):. PubMed ID: 34035154
[TBL] [Abstract][Full Text] [Related]
31. Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
Yamamoto K; Nagashima M; Yoshida I; Sadamasu K; Kurokawa M; Nagashima M; Kinoshita N; Maeda K; Takasaki J; Teruya K; Ohmagari N
J Infect Chemother; 2021 Aug; 27(8):1273-1275. PubMed ID: 34023222
[TBL] [Abstract][Full Text] [Related]
32. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.
McGonagle D; Bridgewood C; Meaney JFM
Lancet Respir Med; 2021 Jun; 9(6):665-672. PubMed ID: 34000237
[TBL] [Abstract][Full Text] [Related]
33. The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.
Chodick G; Tene L; Rotem RS; Patalon T; Gazit S; Ben-Tov A; Weil C; Goldshtein I; Twig G; Cohen D; Muhsen K
Clin Infect Dis; 2022 Feb; 74(3):472-478. PubMed ID: 33999127
[TBL] [Abstract][Full Text] [Related]
34. Association Between Cigarette Smoking and COVID-19 Outcomes.
Braillon A
JAMA Intern Med; 2021 Aug; 181(8):1137-1138. PubMed ID: 33999121
[No Abstract] [Full Text] [Related]
35. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm.
Mossad SB
Am J Transplant; 2021 Aug; 21(8):2908. PubMed ID: 33998136
[No Abstract] [Full Text] [Related]
36. Do asymptomatic carriers of SARS-COV-2 transmit the virus?
Muller CP
Lancet Reg Health Eur; 2021 May; 4():100082. PubMed ID: 33997832
[No Abstract] [Full Text] [Related]
37. Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study.
Strålin K; Wahlström E; Walther S; Bennet-Bark AM; Heurgren M; Lindén T; Holm J; Hanberger H
Lancet Reg Health Eur; 2021 May; 4():100054. PubMed ID: 33997829
[TBL] [Abstract][Full Text] [Related]
38. Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ
Cell Rep Med; 2021 Jun; 2(6):100296. PubMed ID: 33997824
[TBL] [Abstract][Full Text] [Related]
39. Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates.
Luo S; Zhang P; Liu B; Yang C; Liang C; Wang Q; Zhang L; Tang X; Li J; Hou S; Zeng J; Fu Y; Allain JP; Li T; Zhang Y; Li C
Emerg Microbes Infect; 2021 Dec; 10(1):1002-1015. PubMed ID: 33993845
[No Abstract] [Full Text] [Related]
40. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
